Latest 10-K annual reports

DBV Technologies provides an overview of its ordinary shares, American Depositary Shares, corporate governance practices, and executive compensation in its amended 10-K filing.

Coya Therapeutics files an amendment to its annual report on Form 10-K/A to include previously omitted Part III information and updated certifications.

Evolv Technologies Holdings restates past financial statements following an investigation into sales practices and revenue recognition.

Ultralife Corporation files an amendment to its annual report on Form 10-K to include information on directors, executive officers, corporate governance, and executive compensation.

2seventy bio files an amendment to its 2024 Annual Report on Form 10-K to include previously omitted information regarding directors, executive officers, and corporate governance.

Rocket Companies files an amendment to its 2024 10-K report, detailing a planned Up-C structure collapse, acquisitions of Redfin and Mr. Cooper, and executive compensation.

XWELL, Inc. amends its original Form 10-K filing to include Part III information and updated certifications due to the absence of a definitive proxy statement.

Beeline Holdings files an amendment to its annual report on Form 10-K to include information required by Part III, which was initially omitted due to the delay in filing the definitive proxy statement.

Interpace Biosciences files an amendment to its 2024 Annual Report on Form 10-K to include information that was to be incorporated by reference from the company's definitive proxy statement.

Fossil Group files an amendment to its 2024 Annual Report on Form 10-K to include previously omitted information regarding directors, executive officers, compensation, and related matters.

Canadian Pacific Kansas City (CPKC) filed an amendment to its 2024 Annual Report on Form 10-K/A to include Part III information regarding directors, executive officers, and corporate governance.

NEXT-ChemX Corporation files an amended 10-K/A report addressing auditor issues, restating financials due to a change in intangible asset valuation, and including a cybersecurity disclosure.

CERo Therapeutics Holdings files an amendment to its annual report to include information required by Part III of Form 10-K, covering details about directors, executive officers, compensation, and corporate governance.

Enzon Pharmaceuticals files an amendment to its 2024 Annual Report on Form 10-K to include Part III information and an updated certification from its principal executive and financial officer.

Glen Burnie Bancorp reports a net loss of $112,000 for 2024, while experiencing growth in its loan portfolio.

NV5 Global files an amendment to its 10-K annual report, providing details on directors, executive compensation, corporate governance, and related matters.

Via Renewables, Inc. files an amendment to its 2024 annual report to include required information in Part III (Items 10-14) regarding directors, executive compensation, security ownership, related transactions, and accounting fees.

Heritage Distilling Holding Company files an amendment to its 2024 annual report to include its Clawback Policy, which was inadvertently omitted in the original filing.

Quality Industrial Corp. achieves profitability in 2024, driven by the acquisition of Al Shola Gas, marking a significant turnaround from the previous year's losses.

Heritage Distilling Holding Company's 10-K filing reveals a year of strategic shifts, financial hurdles, and ongoing efforts to expand its market presence and brand recognition.

RadNet, Inc. amends its original Form 10-K filing to include the Insider Trading Policy, which was inadvertently omitted.

Akoya Biosciences files an amendment to its 2024 Annual Report on Form 10-K to include information required by Part III, covering directors, executive officers, compensation, and corporate governance.

Redfin Corporation files an amendment to its 2024 annual report to include Part III information regarding directors, executive officers, and corporate governance, initially omitted in reliance on General Instruction G(3) to Form 10-K.

Golden Entertainment files an amendment to its 2024 Form 10-K solely to correct the date of the former auditor's opinion.

System1, Inc. files an amendment to its 2024 annual report on Form 10-K to include information on directors, executive compensation, and related matters previously intended to be incorporated by reference from a proxy statement.

Wrap Technologies files an amendment to its 2024 annual report on Form 10-K to include information regarding directors, executive officers, corporate governance, and executive compensation.

Creative Medical Technology Holdings files an amendment to its 2024 annual report, providing updates on executive compensation, director information, related party transactions, and other corporate governance matters.

Glidelogic Corp.'s Form 10-K filing reveals a year of diversified software development and consulting efforts in AI, FinTech, and blockchain, with revenue growth and ongoing concerns about the company's ability to continue as a going concern.

180 Life Sciences Corp. files an amendment to its 2024 Annual Report on Form 10-K to include previously omitted disclosures regarding directors, executive compensation, security ownership, related transactions, and principal accountant fees.

RCM Technologies files an amendment to its annual report to include information previously intended to be incorporated by reference from the company's proxy statement.